HKU Scholars Hub: Browsing DSpace

Browsing by Author Kweon, YO

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 10 of 10

	Title	Author(s)	Issue Date
	A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Journal:Journal of Hepatology	Mak, LY Gane, E Schwabe, C Yoon, KT Heo, J Scott, R Lee, JH Lee, JI Kweon, YO Weltman, M Harrison, SA Neuschwander-Tetri, BA Cusi, K Loomba, R Given, BD Christianson, DR Garcia-Medel, E Yi, M Hamilton, J Yuen, RMF	2022
	ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH Proceeding/Conference:Journal of Hepatology	Gane, E Schwabe, C Yoon, KT Heo, J Scott, R Lee, J Lee, JIL Kweon, YO Weltman, M Harrison, S Tetri, B Cusi, K Loomba, R Christianson, D Rajicic, N Martin, JS Hamilton, J Yuen, RMF	2021
	Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos(t)ide analogue (NA)-naïve CHB patients: phase 2a, randomized, double-blind, placebo-controlled study. Proceeding/Conference:Journal of Hepatology	Yuen, RMF Heo, J Jang, JW Yoon, J-H Kweon, YO Park, S-J Bennett, F Kwoh, J	2020
	Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy Proceeding/Conference:Hepatology	Yuen, RMF Heo, J Jang, JW Yoon, JH Kweon, YO Park, SJ Bennett, CF Kwoh, TJ	2019
	Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B Journal:Gut	Lai, CL Ahn, SH Lee, KS Um, SH Cho, M Yoon, SK Lee, JW Park, NH Kweon, YO Sohn, JH Lee, J Kim, JA Han, KH Yuen, RMF	2013
	Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B (CHB) subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study Proceeding/Conference:Hepatology	Yuen, RMF Heo, J Kumada, H Suzuki, F Suzuki, Y Xie, Q Jia, JD Karino, Y Hou, JL Chayama, K Imamura, M lao-Tan, JY Lim, SG Tanaka, Y Xie, W Yoon, JH Duan, ZP Kurosaki, M Park, SJ Labio, E Kumar, R Kweon, YO Yim, HJ Cremer, J Elston, R Chen, SG Davies, M Baptiste-Brown, S Han, K Campbell, F Paff, M Theodore, D	2019
	Telbivudine combination with adefovir versus adefovir monotherapy in HBeAg-positive chronic hepatitis B (CHB) patients with lamivudine resistance Proceeding/Conference:Hepatology International	Ahn, SH Kweon, YO Paik, SW Sohn, JH Lee, KS Kim, DJ Piratvisuth, T Yuen, RMF Trylesinski, A Avila, C	2010
	Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B Journal:Hepatology International	Ahn, SH Kweon, YO Paik, SW Sohn, JH Lee, KS Kim, DJ Piratvisuth, T Yuen, MF Chutaputti, A Chao, YC Trylesinski, A Avila, C	2012
	Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study Journal:Journal of Hepatology	Yuen, RMF Ahn, SH Lee, KS Um, SH Cho, M Yoon, SK Lee, JW Park, NH Kweon, YO Sohn, JH Lee, J Kim, JA Lai, CL Han, KH	2015
	Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B Proceeding/Conference:Hepatology	Lai, CL Ahh, SH Lee, KS Um, SH Cho, M Yoon, SK Lee, JW Park, NH Kweon, YO Sohn, JH Lee, J Kim, JA Han, KH Yuen, MF	2011

Showing results 1 to 10 of 10